Research-Grade Sermorelin Overview
Ultima-Sermorelin 5mg is a synthetic growth hormone releasing hormone (GHRH) analogue manufactured by Ultima Pharmaceuticals for laboratory research applications. This peptide represents a bioactive fragment of human GHRH comprising the first 29 amino acids, which constitute the active sequence necessary for growth hormone receptor binding and activation in cellular models. Research scientists investigating growth hormone pathways can examine this compound’s effects on pituitary somatotroph cells and related signalling cascades. Available through Stroid UK Shop, this research peptide provides laboratories with standardised material for studying growth hormone regulatory mechanisms.
Laboratory Research Applications
Scientific investigations evaluate Ultima-Sermorelin’s capacity to stimulate growth hormone secretion through binding to GHRH receptors on anterior pituitary cells. Researchers studying endocrine physiology can examine this peptide’s role in pulsatile growth hormone release patterns and circadian rhythm modulation in experimental models. Cell culture studies investigate the compound’s effects on somatotroph proliferation and hormone synthesis pathways. Metabolic research laboratories utilise this GHRH analogue to study growth hormone’s downstream effects on insulin-like growth factor-1 production and tissue anabolism. Scientists can explore this peptide alongside other research compounds from our sermorelin acetate collection or examine comparative effects with compounds from our SARMs category for comprehensive endocrine research protocols.
Product Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Sermorelin Acetate |
| Peptide Sequence | GHRH (1-29) Fragment |
| Vial Content | 5mg Lyophilised Powder |
| Manufacturer | Ultima Pharmaceuticals |
| CAS Number | Verify with supplier |
| Molecular Formula | Verify with supplier |
| Storage Requirements | -20°C (lyophilised), 2-8°C (reconstituted) |
| Reconstitution | Bacteriostatic water recommended |
Research laboratories should verify analytical specifications with supplier documentation before commencing experimental protocols. Scientists examining growth hormone regulatory pathways can incorporate this compound into studies alongside materials from our broader peptides research collection for comprehensive endocrine investigation frameworks.
Research Compliance Notice
Ultima-Sermorelin 5mg is manufactured exclusively for in-vitro laboratory research purposes and scientific investigation. This product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Research institutions must ensure proper handling protocols, appropriate storage conditions, and compliance with relevant scientific safety guidelines. Laboratories should maintain detailed research documentation and adhere to institutional review procedures when conducting peptide-based investigations. This compound is restricted to qualified research facilities with appropriate analytical capabilities and safety infrastructure for peptide research applications.
